Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials

Double Blind ◽

Double Blind Placebo ◽

Patient Level Data ◽

Patient Level ◽

Cerebrovascular Events ◽

The safety profile of parecoxib for the treatment of postoperative pain: a pooled analysis of 28 randomized, double-blind, placebo-controlled clinical trials and a review of over 10 years of postauthorization data

Journal of Pain Research ◽

10.2147/jpr.s136052 ◽

2017 ◽

Vol Volume 10 ◽

pp. 2451-2459 ◽

Cited By ~ 12

Author(s):

Stephan Schug ◽

Bruce Parsons ◽

Chunming Li ◽

Feng Xia

Keyword(s):

Clinical Trials ◽

Postoperative Pain ◽

Safety Profile ◽

Pooled Analysis ◽

Double Blind ◽

Double Blind Placebo

Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials

Nephrology ◽

10.1111/nep.12842 ◽

2017 ◽

Vol 22 (10) ◽

pp. 769-775 ◽

Cited By ~ 6

Author(s):

Kazuhiko Tsuruya ◽

Yukari Uemura ◽

Hideki Hirakata ◽

Takanari Kitazono ◽

Yoshiharu Tsubakihara ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Clinical Trials ◽

Polyethylene Glycol ◽

Pooled Analysis ◽

Renal Survival ◽

Patient Level Data ◽

Individual Patient Level ◽

Patient Level ◽

Level Data ◽

Methoxy Polyethylene Glycol

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2015.03.024 ◽

2015 ◽

Vol 66 (3) ◽

pp. 441-449 ◽

Cited By ~ 65

Author(s):

Mark E. Cooper ◽

Vlado Perkovic ◽

Janet B. McGill ◽

Per-Henrik Groop ◽

Christoph Wanner ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Pooled Analysis ◽

Patient Level Data ◽

Dipeptidyl Peptidase 4 ◽

Individual Patient Level ◽

Patient Level ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trials

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2016.07.002 ◽

2016 ◽

Vol 30 (8) ◽

pp. 1622-1630 ◽

Cited By ~ 2

Author(s):

Nobuya Inagaki ◽

Wayne H.-H. Sheu ◽

David R. Owens ◽

Susanne Crowe ◽

Amit Bhandari ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Pooled Analysis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diabetes Patients

Safety and tolerability of linagliptin in Asians with type 2 diabetes: a pooled analysis of 4457 patients from 21 randomized, double-blind, placebo-controlled clinical trials

Expert Opinion on Drug Safety ◽

10.1080/14740338.2022.1999409 ◽

2021 ◽

Author(s):

Keizo Kanasaki ◽

Shen Qu ◽

Fumiko Yamamoto ◽

Cornelia Schepers ◽

Rafael Sani Simões ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trials ◽

Pooled Analysis ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717980033.793479806 ◽

2013 ◽

Author(s):

Robert Sheldon ◽

Tarek Hatoum

Keyword(s):

Myocardial Infarction ◽

Clinical Trials ◽

Primary Prevention ◽

Survival Benefit ◽

Meta Analysis ◽

Implantable Cardioverter Defibrillator Therapy ◽

Patient Level Data ◽

Cardioverter Defibrillator ◽

Patient Level ◽

TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2016.09.216 ◽

2016 ◽

Vol 68 (18) ◽

pp. B27-B28

Author(s):

Rafael Cavalcante ◽

Yohei Sotomi ◽

Pannipa Suwannasom ◽

Cheol Whan Lee ◽

Jung-Min Ahn ◽

...

Keyword(s):

Coronary Disease ◽

Pooled Analysis ◽

Syntax Score ◽

Left Main ◽

Patient Level Data ◽

Individual Patient Level ◽

Patient Level ◽

Level Data ◽

Patients With Diabetes

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Vascular Health and Risk Management ◽

10.2147/vhrm.s170141 ◽

2018 ◽

Vol Volume 14 ◽

pp. 233-246 ◽

Cited By ~ 3

Author(s):

Mireille Fernet ◽

Bruce Beckerman ◽

Paula Abreu ◽

Katharina Lins ◽

John Vincent ◽

...

Keyword(s):

Receptor Antagonist ◽

Mineralocorticoid Receptor ◽

Antihypertensive Effect ◽

Pooled Analysis ◽

Mineralocorticoid Receptor Antagonist ◽

Patient Level Data ◽

Patient Level ◽

Level Data ◽

Comparative Trials

Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD

The American Journal of Medicine ◽

10.1016/j.amjmed.2018.08.005 ◽

2018 ◽

Vol 131 (12) ◽

pp. 1463-1472.e7 ◽

Cited By ~ 10

Author(s):

Steven M. Smith ◽

Matthew J. Gurka ◽

David A. Calhoun ◽

Yan Gong ◽

Carl J. Pepine ◽

...

Keyword(s):

Blood Pressure ◽

Systolic Blood Pressure ◽

Resistant Hypertension ◽

Pooled Analysis ◽

Blood Pressure Target ◽

Patient Level Data ◽

Patient Level ◽

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2010.04126.x ◽

2011 ◽

Vol 9 (2) ◽

pp. 312-319 ◽

Cited By ~ 120

Author(s):

W. SABER ◽

T. MOUA ◽

E. C. WILLIAMS ◽

M. VERSO ◽

G. AGNELLI ◽

...

Keyword(s):

Risk Factors ◽

Clinical Trials ◽

Cancer Patients ◽

Prospective Studies ◽

Meta Analysis ◽

Patient Level Data ◽

Patient Level ◽

Level Data ◽

Catheter Related Thrombosis